Skip to main content
. Author manuscript; available in PMC: 2009 Jul 6.
Published in final edited form as: Biomaterials. 2007 Jul 20;28(30):4355–4369. doi: 10.1016/j.biomaterials.2007.06.019

Table 1.

Rate Parameters Descriptive of FXII Autoactivation in Human Plasma

Hydrophilic Procoagulant Hydrophobic Procoagulant
WF12o μg/mL A ×10−3 PEU/mL·sec B ×10−1 1/sec (%R2, N=8) C PEU/mL×10−3 (N=4) A ×10−3 PEU/mL·sec B ×10−1 1/sec (%R2, N=8) C PEU/mL×10−3 (N=4)
30 (1X) (endogenous) 1.07±0.22 1.43±0.29 (84.0) 7.53±0.13 0 0 0.02±0.01
37.5 (1.25X) (endogenous +7.5 exogenous) 2.63±0.42 2.35±0.37 (89.0) 11.2±0.31 0.11±0.01 1.64±0.18 (92.2) 0.66±0.05
45 (1.5X) (endogenous +15 exogenous) 4.79±0.47 3.15±0.30 (94.7) 15.2±0.28 0.56±0.08 3.00±0.39 (82.4) 1.88±0.12
52.5 (1.75X) (endogenous +22.5 exogenous) 4.90±0.44 2.94±0.24 (95.2) 16.7±0.6 1.21±0.15 4.24±0.50 (82.5) 2.85±0.12
60 (2X) (endogenous +30 exogenous) 5.62±0.58 3.49±0.34 (93.4) 16.1±0.6 1.57±0.21 4.54±0.60 (74.7) 3.45±0.05

Notes: WF12o is the nominal FXII concentration assuming 30 μg/mL normal physiologic concentration. Procoagulants = 150 mm2 nominal surface area of water-wettable (hydrophilic) and silanized-glass (hydrophobic) particles (see Methods and Materials). Error in parameter A=B·C computed by propagation of error; error in parameter B is the standard error of the fit to Eq. 5 of Appendix I; error in parameter C the standard deviation of the mean of N=4 steady-state FXIIa concentrations (see Results).